Developing a national 'low risk' febrile neutropenia framework for use in children and young people's cancer care
- PMID: 23262805
- DOI: 10.1007/s00520-012-1653-y
Developing a national 'low risk' febrile neutropenia framework for use in children and young people's cancer care
Abstract
Purpose: A Delphi study was undertaken to develop a framework guidance that would rationalise and standardise the care of children with febrile neutropenia (FNP) across the UK.
Methods: A mailed Delphi survey was undertaken with health professionals working in children's cancer units. The survey employed two rounds of feedback on 22 practice statements drawn from a systematic review of clinical evidence. Consensus was assumed for any statement where 80+ % of respondents indicated that they "agreed" or "strongly agreed".
Results: Consensus was reached on 21 of the 22 practice statements in round 1 that were categorised into six areas: definition of fever and neutropenia, initial management and choice of antibiotic, defining low-risk patients, strategy in low-risk patients and alternative approaches. Consensus could not be reached on whether patients needed to be afebrile to be suitable for discharge and the required length of outpatient antibiotic treatment.
Conclusions: A Delphi survey allowed the successful development of a national framework for identification and management of children with FNP. The use of an existing well-functioning professional network was key in this project's success.
Similar articles
-
Management of fever and neutropenia in children with cancer: A survey of Australian and New Zealand practice.J Paediatr Child Health. 2018 Jul;54(7):761-769. doi: 10.1111/jpc.13899. Epub 2018 Apr 14. J Paediatr Child Health. 2018. PMID: 29655245
-
Delphi method to identify expert opinion to support children's cancer referral guidelines.Arch Dis Child. 2020 Mar;105(3):241-246. doi: 10.1136/archdischild-2019-317235. Epub 2019 Aug 16. Arch Dis Child. 2020. PMID: 31420330
-
Evolving concepts of management of febrile neutropenia in children with cancer.Med Pediatr Oncol. 2002 Aug;39(2):77-85. doi: 10.1002/mpo.10073. Med Pediatr Oncol. 2002. PMID: 12116054 Review.
-
Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres.Arch Dis Child. 2007 Jun;92(6):495-8. doi: 10.1136/adc.2006.102699. Epub 2007 Feb 6. Arch Dis Child. 2007. PMID: 17284481 Free PMC article.
-
An International Collaborative Consensus Statement on En Bloc Resection of Bladder Tumour Incorporating Two Systematic Reviews, a Two-round Delphi Survey, and a Consensus Meeting.Eur Urol. 2020 Oct;78(4):546-569. doi: 10.1016/j.eururo.2020.04.059. Epub 2020 May 8. Eur Urol. 2020. PMID: 32389447
Cited by
-
The influence of different fever definitions on diagnostics and treatment after diagnosis of fever in chemotherapy-induced neutropenia in children with cancer.PLoS One. 2018 Feb 20;13(2):e0193227. doi: 10.1371/journal.pone.0193227. eCollection 2018. PLoS One. 2018. PMID: 29462193 Free PMC article.
-
The influence of different fever definitions on the rate of fever in neutropenia diagnosed in children with cancer.PLoS One. 2015 Feb 11;10(2):e0117528. doi: 10.1371/journal.pone.0117528. eCollection 2015. PLoS One. 2015. PMID: 25671574 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical